Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-07

Clinical Trial Update: The Safety Evaluation of Silver Alginate (Algidex™) Dressing in Very Low Birth Weight (VLBW) Infants [NA]

View source ↗

Summary

The trial assessed the safety of Silver Alginate (Algidex) dressing in very low birth weight premature infants; results from the completed study were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Algidex Silver Alginate Dressing (silver alginate dressing)

Snippet

Sponsor: Baylor Research Institute | Conditions: Prematurity, Very Low Birth Weight | NA | Status: COMPLETED | Results posted: 2015-04-07